Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Seamlessly bridge your LNP discovery journey from RUO to bulk GLP-tox and GMP excipient-grade material.
Explore CGMP Lipid ServicescKK-E15 is an ionizable cationic lipid and a derivative of cKK-E12 (Item No. 36700) that has been used in the generation of lipid nanoparticles (LNPs).1 LNPs containing cKK-E15 and encapsulating Cre mRNA induce the expression of Cre in Kupffer cells, endothelial cells, and hepatocytes in Ai14 mice engineered to express the fluorescent protein tdTomato upon translation of Cre. Translation of mRNA delivered to the liver by LNPs containing cKK-E15 is inhibited by the toll-like receptor 4 (TLR4) agonist LPS in Ai14 mice but not by low-grade chronic inflammation in a B16/F10 murine model of cancer-induced inflammation. Unlike cKK-E12, the delivery of LNPs containing cKK-E15 is not dependent upon ApoE or Ldlr expression in mice.2
WARNING This product is not for human or veterinary use.
1. Mild innate immune activation overrides efficient nanoparticle-
2. The extent to which lipid nanoparticles require apolipoprotein E and low-